Overcoming Cognitive and Residual Symptoms In Major Depression: Enhancing Patient Outcomes in the Primary Care Setting

This monograph will provide information about the need for understanding and recognizing Depression. Case studies will be presented throughout the monograph which will highlight that disturbances in mood, sleep and concentration are the most common presenting and residual symptoms of depression. Strategies to reduce/minimize side effects will be discussed in addition to the relationship between depression, cognition and treatment options. Pharmacologic therapies will be reviewed highlighting that avoiding the 5HT-2 receptor to minimize sexual dysfunction; and understanding what receptors are targeted by specific antidepressants to maximize benefit while minimizing side to improve patient outcomes. Emphasis is placed on improved communication with the patient regarding utilization of medications for relief of depression and anxiety as well as the need for appropriate referral as needed.

Learning Objective(s):

After completing this program participants should be able to:

  1. Recognize the overlap of emotional, physical and cognitive challenges in patients with major depressive disorder (MDD)
  2. Explore the impact of residual symptoms and cognitive dysfunction on optimal patient outcomes
  3. Develop strategies in the primary care setting to minimize long term side effect burden in an effort to increase adherence to MDD treatment    
  4. Discuss newly approved treatment options for MDD while exploring their role in residual cognitive symptoms, selective side effect profile and remission of depressive symptoms

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.


NACE

Co-Course Director Gregg Sherman, MD Family Practice Northwest Heart and Health Margate, FL Deborah Paschal, CRNP Clinical Nurse Practitioner Cardiothoracic Surgery Division Penn-Presbyterian Medical Center Philadelphia, PA Medical Writer Cedric Nazareth, MBBS Faculty Angela Golden, DNP, Family Nurse Practitioner, NP from Home, LLC, Munds Park, AZ J. Sloan Manning, MD Adjunct Associate Professor, UNC Chapel Hill, Co-Director, Mood Disorders Clinic, Moses Cone Family Medicine Residency, Greensboro, NC Alice R. Mao, MD Professor, Psychiatry & Behavioral Sciences, Baylor College of Medicine, Associate Medical Director, DePelchin Children's Center, Houston, TX Gregg Mattingly, MD Associate Clinical Professor, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO C. Brendan Montano, MD Private Practice, Internal Medicine and Preventive Medicine, Assistant Clinical Instructor, University of Connecticut Health Center, Farmington, CT

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit�. Physicians should only claim the credit commensurate with the extent of their participation in the activity. National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education (which includes 0.75 hours of pharmacology).

Estimated Time to Complete: 1.0 Hours

Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosures are provided below. Angela Golden, DNP, Faculty, has the following relationships to disclose: Advisory Board- Boehringer Ingelheim, Janssen; Advisory Board and Speakers Bureau - Novo Nordisk, Takeda/Lundbeck J. Sloan Manning, MD, Faculty, has the following relationships to disclose: Speakers Bureau - Otsuka, Takeda Lundbeck, Sunovion; Study Investigator- Pearson PLC Alice R. Mao, MD, Faculty, has the following relationships to disclose: Speaker - Takeda, Sunovion, Otsuka, Shire Gregg Mattingly, MD, Faculty has the following relationships to disclose: Speaker � Forest, Lundbeck, Merck, Otsuka, Shire, Sunovion, Takeda; Consultant � Alcobra, Alkermes, Forest, Forum, Jansen, Lundbeck, Merck, Novartis, Noven, Otsuka, Purdue, Reckitt Benckiser, Rhodes, Shire, Sunovion, Takeda C. Brendan Montano, MD, Faculty has the following relationships to disclose: Advisor/Speaker � Merck, Shire, Takeda, Lundbeck, Otsuka; Consultant � Lundbeck, Takeda, Otsuka and Rhodes Gregg Sherman, MD, Co-Course Director, has no relationships to disclose. Deborah Paschal, CRNP, Co-Course Director, has no relationships to disclose. Cedric Nazareth, Medical Writer, has no relationships to disclose. Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationships to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc. Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose. Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose. Sheila Lucas, CWEP, Activity Planning Committee, has no relationships to disclose. Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.

No commercial support was received for this activity.

Enroll Today

Enter your email address to access this course:

Already Registered? Sign In